OA17694A - Method for the detoxification of gluten proteins from grains of cereals. - Google Patents
Method for the detoxification of gluten proteins from grains of cereals. Download PDFInfo
- Publication number
- OA17694A OA17694A OA1201500112 OA17694A OA 17694 A OA17694 A OA 17694A OA 1201500112 OA1201500112 OA 1201500112 OA 17694 A OA17694 A OA 17694A
- Authority
- OA
- OAPI
- Prior art keywords
- gluten
- détoxification
- grains
- toxic
- wheat
- Prior art date
Links
- 108010068370 Glutens Proteins 0.000 title claims abstract description 76
- 235000013339 cereals Nutrition 0.000 title claims description 35
- 238000001784 detoxification Methods 0.000 title description 2
- 235000021312 gluten Nutrition 0.000 claims abstract description 47
- 235000013312 flour Nutrition 0.000 claims abstract description 29
- 235000021307 wheat Nutrition 0.000 claims abstract description 27
- 206010009839 Coeliac disease Diseases 0.000 claims abstract description 18
- 241000209140 Triticum Species 0.000 claims description 26
- 230000002588 toxic Effects 0.000 claims description 25
- 231100000331 toxic Toxicity 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 238000004519 manufacturing process Methods 0.000 claims description 19
- 239000004464 cereal grain Substances 0.000 claims description 6
- 230000036571 hydration Effects 0.000 claims description 6
- 238000006703 hydration reaction Methods 0.000 claims description 6
- 235000007319 Avena orientalis Nutrition 0.000 claims description 5
- 244000075850 Avena orientalis Species 0.000 claims description 5
- 240000005979 Hordeum vulgare Species 0.000 claims description 5
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 4
- 235000013405 beer Nutrition 0.000 claims description 2
- 235000015927 pasta Nutrition 0.000 abstract description 10
- 102000004127 Cytokines Human genes 0.000 abstract description 4
- 108090000695 Cytokines Proteins 0.000 abstract description 4
- 230000002757 inflammatory Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 235000001412 Mediterranean diet Nutrition 0.000 abstract description 2
- 240000008529 Triticum aestivum Species 0.000 abstract description 2
- 235000015173 baked goods and baking mixes Nutrition 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 36
- 102000004169 proteins and genes Human genes 0.000 description 36
- 108090000623 proteins and genes Proteins 0.000 description 36
- 235000013305 food Nutrition 0.000 description 15
- 108010061711 Gliadin Proteins 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 12
- 238000005755 formation reaction Methods 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 235000008429 bread Nutrition 0.000 description 9
- 210000004347 Intestinal Mucosa Anatomy 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108010050792 glutenin Proteins 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- 238000006116 polymerization reaction Methods 0.000 description 7
- 101700024603 ANNU Proteins 0.000 description 6
- 101700034322 TGAS Proteins 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 101700012968 tgl Proteins 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 238000004898 kneading Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- 108010044091 Globulins Proteins 0.000 description 3
- 102000006395 Globulins Human genes 0.000 description 3
- 210000004698 Lymphocytes Anatomy 0.000 description 3
- 210000001744 T-Lymphocytes Anatomy 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 230000002163 immunogen Effects 0.000 description 3
- 230000000968 intestinal Effects 0.000 description 3
- 230000000873 masking Effects 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 102100009596 HP Human genes 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 102000002067 Protein Subunits Human genes 0.000 description 2
- 108010001267 Protein Subunits Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- 240000002057 Secale cereale Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000007264 Triticum durum Nutrition 0.000 description 2
- 241000209143 Triticum turgidum subsp. durum Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 235000005824 corn Nutrition 0.000 description 2
- 238000006481 deamination reaction Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000003960 inflammatory cascade Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- -1 lysine methyl ester Chemical class 0.000 description 2
- 230000000813 microbial Effects 0.000 description 2
- 230000003000 nontoxic Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001131 transforming Effects 0.000 description 2
- 108010027843 zonulin Proteins 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000002399 Aphthous Stomatitis Diseases 0.000 description 1
- 206010059512 Apoptosis Diseases 0.000 description 1
- 210000000349 Chromosomes Anatomy 0.000 description 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010019233 Headache Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 210000000936 Intestines Anatomy 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine zwitterion Chemical group [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 102000003820 Lipoxygenases Human genes 0.000 description 1
- 108090000128 Lipoxygenases Proteins 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108090000437 Peroxidases Proteins 0.000 description 1
- 231100000614 Poison Toxicity 0.000 description 1
- 102100017295 TGM2 Human genes 0.000 description 1
- 230000003187 abdominal Effects 0.000 description 1
- 230000003213 activating Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001476 alcoholic Effects 0.000 description 1
- 108010050181 aleurone Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000001580 bacterial Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000903 blocking Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000001413 cellular Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000002596 correlated Effects 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000001627 detrimental Effects 0.000 description 1
- 230000000378 dietary Effects 0.000 description 1
- 230000001079 digestive Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 150000002019 disulfides Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000001842 enterocyte Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 230000036545 exercise Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002068 genetic Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl radical Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 230000003870 intestinal permeability Effects 0.000 description 1
- 230000003834 intracellular Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 201000008895 mood disease Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000000050 nutritive Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 230000003389 potentiating Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002797 proteolythic Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000036633 rest Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 108010058974 transglutaminase 2 Proteins 0.000 description 1
- 230000001960 triggered Effects 0.000 description 1
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
Abstract
The method allows to obtain gluten detoxified flours suitable for the preparation of bakery products and pasta made from wheat. With the use of the method gluten proteins undergo structural changes that do not activate in patients suffering from celiac disease, the cascade of inflammatory cytokines. Such structural changes, in addition, do not affect the technical properties of the flours that form the dough, therefore allowing the preparation of detoxified products, similar in taste and appearance to those commonly used in Mediterranean diet and which are intended not only for the people who suffer from intolerance to gluten, but for the whole population. The widespread use of such detoxified products in large part of the population has the purpose, in a totally innovative way, to provoke the reduction of gluten's effects in people's health and therefore to the decrease in the incidence of celiac disease.
Description
METHOD FOR THE DETOXIFICATION OF GLUTEN PROTEINS FROM GRAINS OF CEREALS
FIELD OF THE INVENTION
The présent invention proposes a method for the détoxification of gluten proteins s from grains of cereals, in particular from the grains of wheat, aimed to obtain detoxified flours for the préparation of bread and pasta products, from wheat, preferably suitable for the alimentation of patients with celiac disease, but also adéquate for its organoleptic characteristics and for its aspect, for the alimentation of the whole population.
i n BACKGROUND TO THE INVENTION
Technical note.
Gluten is a food component constituted principally by proteins. Prolamines represent about 80% of the entire protein fraction présent in the cereal caryopsis and are principally constituted by gliadin and glutenin.
s Gliadins are monomeric molécules typically classified in alpha, beta, gamma, and oméga (according to electrophoretic mobility) for which the monomer condition is due to the absence of cysteine rests as in the case of omega-gliadins, or to the presence of only intra-molecular disulfide bonds (the remaining gliadins).
Glutenins, however, are a complex polymer, constituted of subunits of high (HMW20 GS) and low (LMW-GS) molecular weight, stabilized by disulfide intermolecular bridges. Gliadin and glutenin confer technological properties to the flour; gliadins contribute to viscosity of the dough, while glutenins are responsible for the elasticity and toughness of the same.
In particular, the quantity and size of the glutenin polymers are positively correlated 25 with the technological properties of the dough.
These characteristics of glutenin polymers therefore dépend on the ability of the individual subunits to form more or less extended polymers. The gluten, in particular, is not présent in the cereal caryopsis, but is formed in a later moment; gluten as a protein complex is formed as a conséquence of hydration and kneading of the dough 3Q and constitutes an essential element for the production of flour and bread as it confers viscosity and elasticity to the dough. As it is known, when water is added to the flour, gliadins (consisting of a single chain protein) begin to combine one to each other forming fibrils (small and thin fibres) that confer extensibility to the mass of gluten. Simultaneously, also the glutenins (composed of different protein subunits) combine one to each other, creating fibres of larger dimensions and forming a structure, stable 5 and very cohesive, which gives consistency and a certain résistance extension to the dough. The strength and degree of leavening of the dough therefore dépend on the proportion between gliadin and glutenin content in the flour. The relationship between the two classes of proteins dépends on the variety of cereal and gives to the gluten the ability to deform and resist distension.
q During the mechanical action of kneading, the fibrils of the fibres of glutenin and gliadin begin to intertwine with each other, forming a three-dimensional mesh that incorporâtes starch granules (Fig. 1), lipids, minerais, water and air bubbles, the latter very important product of the alcoholic fermentation of yeast. When yeast are added to the dough, the production of alcohol and carbon dioxide détermine the expansion of meshes of gluten, which widen and relax to grow the volume of the same dough.
The subséquent cooking détermines the dénaturation / coagulation of the proteins and so the gluten, losing the ability to extend, stabilizes in an irréversible manner the structure and shape of the dough.
Gluten as a protein complex has no particular nutritive properties, as it is poor in 20 essential amino acids such as lysine, méthionine and tryptophan.
The absence of this compound in the diet does not involve any spécifie nutritional risk.
On the other hand, gluten is capable of performing toxic activity in particular against intestinal mucosa; therefore the permanent intolérance to gluten of wheat and the corresponding proteins of rye, barley and oats, which enable the inflammatory cascade of inflammatory cytokines, is defined as celiac disease.
Initially, it was thought that the toxic action of the gluten could be attributed to the alpha gliadin fraction; subsequently it was demonstrated that even the oméga gliadins and glutenins are able to induce damage to the intestinal mucosa, as well as the 30 prolamines of related cereals such as barley (ordeine), rye (secaline), and oats (avenine).
Of recent interest is the study of a peptide of 33 amino acids of said alpha-gliadin, called 33-mer; said peptide is able to resist the proteolytic activity of digestive enzymes reaching intact the intestinal mucosa, where, having a high affinity for tissue transglutaminase, it exercises a potent immunogenic action in individuals at risk;
such action would be determined, following the deamination of the toxic epitopes from peptide, by an intense activation of lymphocytes that TCD4 which release 5 inflammatory cytokines (Shuppan et al., 2009).
In addition, it has been shown that other toxic epitopes of alpha-gliadin would be able to induce apoptosis of enterocytes deriving from expiants of the intestinal mucosa of celiac patients.
Therefore, gluten exerts a detrimental effect on intestinal mucosa by activating the inflammatory cascade of cytokines, and by causing a direct toxic effect. Dietary therapy of celiac disease was initially based on total élimination from diet of ali grains and food containing gluten (especially bread and pasta, well-known products obtained from wheat, and other food of the Mediterranean alimentation) in the moment in which symptoms of such intolérance, such as abdominal pain, abdominal 15 bloating, gastritis, aphthous stomatitis, mood disorders, headaches etc., appeared; this treatment allowed patients to obtain the decrease of symptoms and the recovery of the intestinal mucosa structure, if the typical lésions were présent. This therapy, however, involves the difficulty of continuance in time, as it créâtes enormous limitations in the diet of patients, and consequently in the social activities related to food; in order to 20 solve these problems it was decided to produce gluten-free food for persons intolérant to gluten, or food where the gluten could not activate the inflammatory reaction, in order to allow patients to hâve a normal lifestyle by eating food that partly resembled in taste and appearance to bread and pasta.
Currently, some methods are known thanks to which the toxic action of the gluten has 25 been partially tumed off.
A method in experimental phase that has not shown the desired effect has been to create wheat detoxified through genetic manipulation, ie, modified in such a way as not to contain the immunogenic sequences that govem the production of toxic epitopes of gluten can stimulate lymphocytes T.
,θ A first limitation of this method consists in the difficulty of identifying ail gene sequences (currently about forty, placed on six loci of two different chromosomes) that govern the coding of immunologically active peptides contained within the primary structure of gluten proteins; this method, moreover, does not guarantee a r t certain resuit as there is a high possibility of having not yet known gene sequences that encode other toxic epitopes.
Another limitation could be the lack of confidence of the consumer to consume for a long time genetically modified products and, therefore, the difïïculty of such products to enter the market to a destination generically aimed at the entire population.
Another method of the prior art, however, provides the use of enzymes (Rizzello et al., 2007) which is a supplémentation with endopeptidase of bacterial origin added during the préparation of the of flour, capable of fragmenting the gluten proteins and, in particular, the fragment 33-mer. A limitation of this method is that it is be very expensive in because it involves the use of purified enzymes; the potential use is only in food intended for celiac patients and it becomes consequently very expensive for the high costs of production.
A second limitation of this method is that the use of these enzymes results in the total destruction of gluten network and, consequently, the loss of dough technological properties that cannot be used for the transformation processes in bread or pasta and so you hâve to resort to tricks structuring such substances (gums, polysaccharides, pregelatinized starch, agar, etc..).
Another method known in the prior art, is the use of microbial enzymes (transglutaminase) in presence of lysine methyl ester to detoxify, by deamidation, toxic epitopes présent in wheat gliadin (Gianfrani et al., 2007). This method has the advantage in comparison to the previous methods, to preserve the gluten network and maintain, therefore, the technological properties of the flours. A limitation of this method is that it is very expensive because it involves the use of purified enzymes; the potential use is only in food intended for celiac patients and it becomes consequently very expensive for the high costs of production.
Another significant limitation is that the détoxification dépends on the concentration of both toxic proteins and microbial enzyme, as well as by the kinetics of reaction. For these reasons the experiments may not give a certain resuit.
An alternative to solve the problem of gluten intolérance could be the use of inhibitors of zonulin (Fasano, 2008), a protein that appears to play a key rôle in altering intestinal permeability.
This method, however, neglects the fact that the transmission of the toxic gliadin does not occur just by intercellular way (which can be blocked by the inhibitor of zonulin) but also by intracellular way.
It is because of this necessity, i.e. to produce typical food of the Mediterranean diet, 5 such as bread and pasta derived from wheat, in which gluten is not toxic for people with celiac disease, and that can be consumed, for flavour and appearance, by the entire population, that this invention was created.
Purpose of the présent invention is to overcome said disadvantages of the prior art by proposing a method of détoxification of gluten proteins, in particular, from grains of 1 θ wheat, and also other cereals, through exposure to microwaves of these, after having undergone a process of hydration.
The présent invention, in fact, is aimed to solve, in particular, the technical problem of the production of food, bread and pasta intended for patients with celiac disease, and deprivation of flour from the toxic gluten action without losing its technical 15 properties to form the dough.
More particularly, the présent invention, by the treatment of the mature grain with microwave, mainly wants to solve the technical problem of the production of flours with detoxified gluten that, at the same time, are suited for the technical production of pasta, bread and production of bakery products from wheat, without loosing the 20 formation of the gluten network.
Finally, the présent invention, through the production of flours and, consequently, of food products such as bread and pasta detoxified from toxic epitopes of gluten, aims to produce food derived from wheat and équivalent in taste and appearance to those commonly used in the Mediterranean alimentation which détermine, through their use 25 in time and by a large part of the population, not only in people with celiac disease, a réduction of the incidence of celiac disease in the population and consequently also the économie impact of the production of spécifie food products for people with celiac disease.
This has been achieved with a method of détoxification according to claim 1.
Brief description of drawings
The présent invention will now be described, as illustrative way, but without limitation, with particular reference to the accompanying figures, in which:
Figure 1 shows the three-dimensional network that incorporâtes the starch granules and that is formed in the presence of water, during the mechanical action of kneading, from the binding of gliadin and glutenin;
Figure 2 shows the electrophoretic profile of gliadins extracted from different 5 samples (A, B, C, D, E, F, G, H) out of which the samples A and B were treated with the method of détoxification of the object présent invention;
Figure 3 shows the protein profile of detoxified semolina (Fig. 3a are soluble protein and insoluble protein are Fig 3b) by way of SE-HPLC analysis;
Figure 4 shows a graph that shows the production of interferon in T lymphocyte lines 1 o generated by intestinal mucosa of patients with celiac disease;
Figure 5 shows the gluten network that is formed after the treatment in the micro wave mature grains (a) and the gluten network that is formed naturally (b);
Figure 6 shows the mode of masking the toxic epitope following the détoxification treatment, such as to render the attachment site of gliadins not accessible and / or 15 unrecognizable at the intestinal level by the transglutaminase, which in conditions of celiac disease induces the immune response.
Description of the invention
In the présent invention, a method that provides for the détoxification of gluten proteins, in particular from wheat grain, is described.
The method for making said flour detoxified by toxic epitopes of gluten comprises the following phases:
A) Hydration of the grains, in particular that of wheat, with mains water for about 1 hour; for 100 grams of mature grains 500 ml of water is added. This phase is necessary to trigger the chemical reactions functional to the détoxification of gluten proteins.
B) Removal of the water. This phase is carried out by draining with a sieve to retain the grains and remove the water.
C) Microwave treatment of hydrated grains for two minutes using a power of 1000 Watt. At this stage what is important, is not the température within the oven, but the power of the electromagnetic waves that trigger through the water contained in the grains, the reactions of détoxifîcation.
D) Cooling of the cereal grains treated with microwaves at room température (20 ° - °C).
- 1’ > >
Ail the phases described above are mandatory: the hydration of the grains for an hour allowing the seed to accumulate the amount of water required to trigger, in the presence of electromagnetic waves, the détoxification reactions of gluten.
The power of 1000 Watt, applied according to the previously described procedure, is sufficient for two minutes in order that the energy accumulated by the water favours the production of singlet oxygen radicals, hydroxyl radical or hydrogen by the cellular metabolism (peroxidases, lipoxygenase, etc..). These highly reactive compounds inside the seed of wheat involve polymerization reactions of gluten proteins localized in sectors different from the caryopsis (protein bodies présent in the aleurone layer and protein bodies présent in the endosperm) by intermolecular bonds and / or intramolecular bonds with conformational change.
The slowly cooling to a température of about 20 ° C allows the completion of the chemical reactions triggered by the action of the electromagnetic waves and the water.
The method illustrated in the présent invention is based on the analysis of recent studies in which Lamacchia and others (2010) hâve reported that, when the high températures are applied to the caryopsis of wheat, the proteins undergo changes that are not similar to those seen in model Systems, consisting only of gluten (Schofield et al., 1983; Singh and MacRitchie, 2004), nor to those seen in the pasta during the drying cycles.
In particular, albumins and globulins are not incorporated in the polymers of high molecular weight but coagulate and interact with gliadins forming an aggregate of molecular weight intermediate to that of gliadins and albumins and globulins revealed as a new peak called Intermediate Protein (IP) peak.
The participation of ω-gliadins to these changes suggests that the interaction between the proteins takes place not only through the formation of disulfide bonds but also through the formation of covalent bonds involving tyrosine residues.
The researchers Lamacchia and others (2010) explained this phenomenon on the basis of the fact that in the caryopsis of wheat, gluten is not yet formed and gluten proteins are deposited in different protein bodies (Rubin et al., 1992, Krishnan et al., 1986; Lending et al., 1989).
In a recent study, Tosi and others (2009) confirmed, in fact, that the HMW are particularly abundant in the innermost layer of the caryopsis of wheat (endosperm) and practically absent in the subaleuronic layer which, however, is rich in gliadins and LMW.
This pattern of déposition is maintained throughout ail the development phase of the caryopsis of wheat and continues even after the merger of protein bodies and the 5 formation of the starchy matrix.
Therefore, the ségrégation of gluten proteins in protein bodies when they are in the caryopsis and the application of high températures in this stage before the milling, would allow such proteins of experiencing structural changes such as not to make them recognizable anymore by intestinal transglutaminase, thereby blocking the 1 q waterfall of inflammatory cytokine.
The grains, hydrated and subjected to treatment with microwaves, generates water radicals that trigger the polymerization of gluten proteins.
This polymerization appears to be favoured when gluten proteins are segregated in the protein bodies due to the fact that within these protein bodies are very close to 15 each other allowing an easy interaction between the various classes depending on the type of body protein in which they are; in the case of the vacuolar protein bodies (aleuronic layer) we can hâve interactions between gliadins, LMW and albumins / globulins, in the case of protein bodies of endoplasmic type (endosperm layer) we can only hâve interactions between HMW.
The polymerization induced by the water and by the electromagnetic waves does not détermine the loss of free sulfhydryl groups, necessary for the formation of gluten, resulting in a protein network although different in conformation (Fig. 5a) (due to the interaction of the different aggregates mentioned above) from the gluten network which is formed naturally (Fig. 5b), but which ensures the adéquate technological 25 properties of transformation of wheat flour in a final product.
The polymerization of gluten proteins by water radicals favoured by electromagnetic waves produces the formation of covalent bonds between these gluten proteins. The formation of these bonds between gluten proteins inside the protein bodies allows a sort of masking of the toxic epitope, as shown in Figure 6, such as to make the site of 3θ attack of gliadins not accessible and / or not recognizable at the intestinal level by the transglutaminase, which in celiac disease conditions induces the immune response.
The structural changes of gluten proteins of detoxified flours are highlighted through the test that can détermine the gluten index, evaluating the strength of the same.
The gluten of detoxified flours, passing completely through the grid of the device, undergoes a leaching of the components of the grain, evidencing the presence of structural changes in the gluten protein.
These structural changes of the gluten of detoxified flours are better analyzed in Figures 2 and 3; Figure 2 shows the change of the protein pattern of gliadins extracted from different samples of grains treated with the method of détoxification object of the présent invention (A and B - durum wheat semolina), compâred with other untreated samples (C, D, E - durum wheat semolina, F, G, H - soft wheat flour), the gliadins are gluten proteins which are soluble in alcohol that contain toxic epitopes recognized in the intestine.
The decrease in the intensity of the electrophoresis bands indicates a qualitative and quantitative change of gliadins.
Quantitative because most of them, due to the processes of polymerization induced by the microwave treatment, hâve been rendered insoluble in an éthanol solution to 70% and therefore not détectable on the electrophoresis gel.
Qualitative because the few visible bands are however aggregates of gliadins (which undergo a polymerization by microwaves) to the lowest molecular weight and therefore extractable in éthanol solution and détectable on the electrophoresis gel, but however non-toxic in accordance with the immunological fmdings performed in vitro (Fig· 4).
Figures 3a and 3b, on the other side, show two graphs that indicate the protein profile of respectively soluble and insoluble proteins, extracted from detoxified grains (the curves with shades of gray dark) and untreated grians (the curve with shades of lighter gray) by SE-HPLC; figure 3a indicates two main peaks, one on the right that represents the polymers of high molecular weight (HMW and LMW); the one on the left represents the oligomers and monomers of gliadin; the graph shows the decrease of the solubility of gluten proteins after the détoxification treatment of the présent invention.
Figure 3b indicates an increase of the two peaks in the detoxified flour, indicating an increase in insoluble proteins after the treatment of détoxifîcation.
These structural changes of gluten proteins would be likely to deprive gluten from its toxicity, thanks to a masking of the attack site of the transglutaminase (Fig. 6) and allowing the maintenance of the technical properties of the dough due to the maintenance of the free sulfhydryl groups, necessary for the formation of the gluten network (Figs. 5a and 5b).
Regarding the gluten’s loss of toxicity présent in treated flours, Figure 4 shows a graph of a test of immunological cells lymphocytes (T cells) of celiac patients; in this 5 chart the production of interferon-γ in lines of T lymphocytes taken from intestinal mucosa of celiac patients is represented; the cellular lines hâve been proved to be highly responsive to gliadin from hexaploid wheat (tryptic digest Pepto- PT) after deamination with transglutaminase tissue, while any immunological reactivity to gliadin extracted from flours A and B treated at concentrations of 50 and 100 mg / ml 1 o has been observed.
Lastly, regarding the maintenance of technological properties of the detoxified flour, we know that in the kneading with water, the flour absorbs water causing the binding of gliadins and glutenins and, therefore, the formation of gluten network that influence the formation of the viscoelastic mass for entraining gas.
Flour detoxified by this method retains the ability to kneading the dough as it does not loose the ability to form bonds between free cysteine disulfide groups (Figures 5a and 5b) necessary for the formation of the network; the dough obtained with the detoxified flours maintains the characteristic of extensibility, which, as is known, is mainly due to gliadin, loosing partially elasticity and viscosity due to the formation of 20 aggregates of protein bodies through covalent bonds.
In particular, the loss of a part of elasticity is due to the interaction between the sub units of HMW, through covalent bonds that involve amino acids of the central domain of the protein subunit of high molecular weight, which is known, from studies in the literature, determining the elasticity of the dough.
The loss of viscosity of the dough is instead due to the interaction of the gliadins between them, as they are responsible for this rheological characteristic.
Additional advantages of the invention
A first advantage of the method is that from those grains and flour it will be possible to produce non-toxic food for people with celiac desease, with organoleptic 3θ characteristics équivalent in taste and appearance to those commonly used in the Mediterranean alimentation.
The second advantage is an économie advantage, due to the raw material used, wheat (Italy is one of the largest producers of wheat in the world), instead of corn and ail structuring substances (tires, agar, gélatine, etc.) which are expensive, but also for the use during the expérimentation of only mains water and electromagnetic waves for a short time; consequently, the gluten-free products will no longer be expensive as they are now.
The third advantage is of health type, as the wheat flours are less starchy than those of corn (used until know for the production of gluten-free products) and therefore the resulting products are characterized by a more low glycémie index and therefore such products would be idéal for the feeding of patients who, in addition to celiac disease, also suffer from Diabètes Mellitus type 1, an association frequently observed because of the likeiy common genetic substrate shared by the two diseases.
The fourth advantage is the simplicity the procedure, easily applicable also to other grains including, for example, the barley to produce beer, free from toxic ordeine (proteins similar to the gliadins of wheat) or oats for make products for breakfast, also free from toxic substances (proteins similar to gliadins of wheat).
The fifth advantage is the production of foods that détermine, through their use in time and by large numbers of the population, not only people with celiac disease, a réduction in the incidence of celiac disease in the population due to the smaller immunogenic effect of the detoxified product
The présent invention has been described for illustrative purpose, without limitation, but it is to be understood that variations and / or modifications may be made by the 20 experts in the art without departing from the scope of protection, as defmed by enclosed claims.
Claims (14)
1. Method for the détoxification of gluten proteins from grains of cereals, characterized by the following phases:
A. hydration with water of the cereal grains;
B. removal of water from the cereal grains;
C. microwave treatment of the cereal grains;
D. cooling of the cereal grains.
2. Method for the détoxification of gluten proteins according to claim 1, characterized in that the step of hydration of the grains is performed in a time ffame between 30 minutes and 3 hours and involves the use of 500 ml of water for every 100 grams of grains.
3. Method for the détoxification of gluten proteins according to claim 2 characterized in that the time frame is of approximately one hour.
4. Method for the détoxification of gluten proteins according to claim 1 characterized in that the removal of water phase is performed by drainage by means of a sieve.
5. Method for the détoxification of gluten proteins according to claim 1, characterized in that the phase of microwave treatment of the grains is performed in a time frame between one and three minutes, using a power between 750 and 1500 watts.
6. Method for the détoxification of gluten proteins according to claim 5 characterized in that the time interval is of preferably two minutes and the used power is of 1000 watts.
7. Method for the détoxification of gluten proteins according to claim 1 characterized in that the cooling phase of the grains is performed at a température between 18 ° C and 24 ° C.
8. Application of the method according to claims from 1 to 7 for the détoxification of wheat from gluten toxic epitopes.
9. Utilization of wheat obtained according to claim 8 for the production of semolina and flour for people with celiac disease and for people suffering from Diabètes Mellitus Type 1.
10. Application of the method according to claims from 1 to 7 for the détoxification of barley from toxic epitopes of gluten.
11. Utilization of the barley obtained according to claim 10 for the production of beer free from toxic ordeine.
12. Application of the method according to claims from 1 to 7 for the détoxification of oats from toxic epitopes of gluten.
5
13. Utilization of the oats obtained according to claim 12 for the production of products free from toxic avenine.
14. Utilization of the flour made of cereal grains, detoxified from toxic epitopes of gluten according to the method described in claims from 1 to 7, for the préparation of foodstuff suitable for people with celiac disease and équivalent, in taste and 1 o appearance, to foodstuff commonly used in the Medi
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM2012A000468 | 2012-10-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
OA17694A true OA17694A (en) | 2017-09-19 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2886624C (en) | Method for the detoxification of gluten proteins from grains of cereals | |
Zhu | Buckwheat proteins and peptides: Biological functions and food applications | |
Rustgi et al. | Wheat seed proteins: factors influencing their content, composition, and technological properties, and strategies to reduce adverse reactions | |
Wang et al. | Processing, nutrition, and functionality of hempseed protein: A review | |
Gobbetti et al. | Sourdough lactobacilli and celiac disease | |
Gobbetti et al. | How the sourdough may affect the functional features of leavened baked goods | |
Stoven et al. | Celiac disease: advances in treatment via gluten modification | |
Mollakhalili Meybodi et al. | Gluten-Free Bread Quality: A Review of the Improving Factors. | |
Asrani et al. | Millets as an alternative diet for gluten-sensitive individuals: A critical review on nutritional components, sensitivities and popularity of wheat and millets among consumers | |
Shevkani et al. | Antioxidative and antimicrobial properties of pulse proteins and their applications in gluten‐free foods and sports nutrition | |
Martínez-Velasco et al. | Effect of the preparation method and storage time on the in vitro protein digestibility of maize tortillas | |
Ribes et al. | Oral impairments decrease the nutrient bioaccessibility of bread in the elderly | |
KR20180099662A (en) | Methods for the Detoxification of Gluten Protein from Grain Kernels and Their Uses in Medical Fields | |
Zhang et al. | Detoxification of wheat gluten by enzymatic transamidation under reducing condition and its application in typical food model | |
OA17694A (en) | Method for the detoxification of gluten proteins from grains of cereals. | |
Arendt et al. | Processing Gluten‐Free Foods | |
Chawla et al. | Sourdough in bread-making: An ancient technology to solve modern issues | |
Kumagai | Wheat proteins and peptides | |
Zhang et al. | A review of gluten detoxification in wheat for food applications: approaches, mechanisms, and implications | |
Imam et al. | Application of legumes in the formulation of gluten-free foods: functional, nutritional and nutraceutical importance | |
Martínez-Cruz et al. | Biochemical characteristics, and nutraceutical and technological uses of amaranth globulins | |
JP2009148248A (en) | Allergen-reducing agent | |
Li et al. | Plant-based proteins: advances in their sources, digestive profiles in vitro and potential health benefits | |
Vélez et al. | Health benefits of chickpea and cowpea | |
Prandi | Celiac disease: gluten peptides characterization after in vitro digestion |